Looks at a copper-based therapy for Alzheimer's and examines prospects for repurposing using existing human safety data.
Key Takeaways
- Copper compound restored brain clearance of toxic Alzheimer's proteins in laboratory experiments
- It dramatically reduced amyloid plaque buildup and improved memory in those experiments
- Compound has prior human testing for other neurological conditions enabling repurposing potential